Nava Therapeutics

Nava is building a new class of genetic medicines harnessing novel lipid nanoparticles (LNPs) able to deliver RNA therapeutics to organs and cellular targets with unparalleled precision and efficiency. This approach powers breakthroughs across the full spectrum of RNA therapeutics. _By delivering therapies exactly where needed, we are opening new possibilities for patients with serious diseases that remain beyond the reach of current treatments._ We are unlocking the full potential of genetic medicine by addressing some of its most pressing challenges: delivering RNA safely and precisely to the right cells at clinically relevant doses. Through rational design and exploration of novel chemical space, Nava has built a modular platform of LNPs with unique and selective tropism for a broad range of tissues. Our LNPs enable safe and precise RNA delivery to organs and cellular targets of choice, with an initial therapeutic focus on areas of high unmet medical need.